Description
These guiding principles provide support for Australian public hospitals with the governance of Medicines Access Programs (MAP). These Principles cover all programs offered by pharmaceutical companies to facilitate deferred cost, cost-free or subsidised access to medicines for people in hospital before subsidised listing on the Pharmaceutical Benefits Scheme (PBS), hospital formulary or other relevant funding arrangement.
The guiding principles are intended to assist Medicines and Therapeutics Advisory Committees (MTC), health professionals, consumers and pharmaceutical companies with the appropriate implementation, management, delegation of authority, provision of information and oversight of MAP.
A consumer resource is available to assist with explaining MAPs.